Holm Zaehres

Prof. Dr. Holm Zaehres

Medical Faculty, Anatomy, Ruhr University Bochum, Bochum, North Rhine-Westphalia, Germany
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in Cell
Verified
Journal Article
Closed access
JKJeong Beom Kim
Jeong Beom Kim
VSVittorio Sebastiano
Vittorio Sebastiano
GWGuangming Wu
Guangming Wu
MAMarcos J. Araúzo-Bravo
Marcos J. Araúzo-Bravo
PSPhilipp Sasse
Philipp Sasse
HSHans R. Schöler
Hans R. Schöler

29 June 2008 in Nature
Verified
Journal Article
Closed access
JKJeong Beom Kim
Jeong Beom Kim
Holm ZaehresHolm Zaehres
Holm Zaehres
GWGuangming Wu
Guangming Wu
LGLuca Gentile
Luca Gentile
KKKinarm Ko
Kinarm Ko
HSHans R. Schöler
Hans R. Schöler

28 August 2009 in Nature
Verified
Journal Article
Closed access
JKJeong Beom Kim
Jeong Beom Kim
BGBoris Greber
Boris Greber
MAMarcos J. Araúzo-Bravo
Marcos J. Araúzo-Bravo
JMJohann Meyer
Johann Meyer
KPKook In Park
Kook In Park
HSHans R. Schöler
Hans R. Schöler

1 April 2012 in Cell Stem Cell
Verified
Journal Article
Closed access
Dong-Wook HanDong-Wook Han
Dong-Wook Han
NTNatalia Tapia
Natalia Tapia
AHAndreas Hermann
Andreas Hermann
KHKathrin Hemmer
Kathrin Hemmer
SHSusanne Höing
Susanne Höing
HSHans R. Schöler
Hans R. Schöler

1 September 2004 in Stem Cells
Verified
Journal Article
Open access
PDF file
LDLaurence Dahéron
Laurence Dahéron
SOSarah L. Opitz
Sarah L. Opitz
Holm ZaehresHolm Zaehres
Holm Zaehres
WLWilliam M. Lensch
William M. Lensch
PAPeter W. Andrews
Peter W. Andrews
GDGeorge Q. Daley
George Q. Daley
STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology. STEM CELLS welcomes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation of their clinical aspects of characterization and manipulation from the bench to patient care. The journal covers all aspects of stem cells embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; stem cell technology: epigenetics, genomics, proteomics, and metabonomics; cancer stem cells; translational and clinical research; and regenerative medicine.

18 April 2011 in Oncogene
Verified
Journal Article
Open access
PDF file
CJC R Jeter
C R Jeter
BLB Liu
B Liu
XLX Liu
X Liu
XCXin Chen
Xin Chen
CLC Liu
C Liu
Dean G. TangDean G. Tang
Dean G. Tang
Cancer cell molecular mimicry of stem cells (SC) imbues neoplastic cells with enhanced proliferative and renewal capacities. In support, numerous mediators of SC self-renewal have been evinced to show oncogenic potential. We have recently reported that short-hairpin RNA-mediated knockdown of the embryonic stem cell (ESC) self-renewal gene NANOG significantly reduced the clonogenic and tumorigenic capabilities of various cancer cells. In this study, we sought to test the potential pro-tumorigenic functions of NANOG, particularly, in prostate cancer (PCa). Using qRT–PCR, we first confirmed that PCa cells expressed NANOG mRNA primarily from the NANOGP8 locus on chromosome 15q14. We then constructed a lentiviral promoter reporter in which the −3.8-kb NANOGP8 genomic fragment was used to drive the expression of green fluorescence protein (GFP). We observed that NANOGP8-GFP+ PCa cells showed cancer stem cell (CSC) characteristics such as enhanced clonal growth and tumor regenerative capacity. To further investigate the functions and mechanisms of NANOG in tumorigenesis, we established tetracycline-inducible NANOG-overexpressing cancer cell lines, including both PCa (Du145 and LNCaP) and breast (MCF-7) cancer cells. NANOG induction promoted drug resistance in MCF-7 cells, tumor regeneration in Du145 cells and, most importantly, castration-resistant tumor development in LNCaP cells. These pro-tumorigenic effects of NANOG were associated with key molecular changes, including an upregulation of molecules such as CXCR4, IGFBP5, CD133 and ALDH1. The present gain-of-function studies, coupled with our recent loss-of-function work, establish the integral role for NANOG in neoplastic processes and shed light on its mechanisms of action.